← All patents

US11344578B2

Immune cells expressing engineered antigen receptors

University of Texas System

Abstract

Provided herein are immune cells expressing antigenic receptors, such as a chimeric antigen receptor and a T cell receptor. Further provided herein are methods of treating immune-related disorder by administering the antigen-specific immune cells.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Katy REZVANI
Priority date
April 19, 2017
Filing date
April 19, 2018
Grant date
May 31, 2022
Publication date
May 31, 2022
Language
en
Metadata fetched
August 29, 2026 00:29